Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Research And Development Expense of $34.89 million for the year ending 2024.
- NORTHWEST BIOTHERAPEUTICS INC showed an increase of +25.8% in Research And Development Expense from 2023 to 2024.
- This data is from NORTHWEST BIOTHERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2010 to 2024 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2024), NORTHWEST BIOTHERAPEUTICS INC's Research And Development Expense has grown by 252.4%.
- Historical annual values: Fiscal year 2024: $34.89 million | Fiscal year 2023: $27.73 million | Fiscal year 2022: $35.51 million | Fiscal year 2021: $20.31 million | Fiscal year 2020: $33.64 million | Fiscal year 2019: $14.11 million | Fiscal year 2018: $18.15 million | Fiscal year 2017: $33.52 million | Fiscal year 2017: $37.0 thousand | Fiscal year 2016: $60.08 million | Fiscal year 2015: $103.12 million | Fiscal year 2014: $85.64 million | Fiscal year 2013: $43.91 million | Fiscal year 2012: $28.91 million | Fiscal year 2011: $13.45 million | Fiscal year 2010: $9.90 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: